1
Clinical Trials associated with METR-NK Cells(Anhui Provincial Cancer Hospital) / Active, not recruitingPhase 1/2IIT Safety and Efficacy of METR-NK Cells Combined With Solantinib Neoadjuvant Therapy in HRD+ Advanced Epithelial Ovarian Cancer: a Single-arm, Single-center, Exploratory Clinical Study
To further evaluate and observe the efficacy and safety of solantinib combined with METR-NK neoadjuvant therapy for advanced epithelial ovarian cancer in patients with advanced epithelial ovarian cancer by using solantinib combined with METR-NK neoadjuvant therapy
100 Clinical Results associated with METR-NK Cells(Anhui Provincial Cancer Hospital)
100 Translational Medicine associated with METR-NK Cells(Anhui Provincial Cancer Hospital)
100 Patents (Medical) associated with METR-NK Cells(Anhui Provincial Cancer Hospital)
100 Deals associated with METR-NK Cells(Anhui Provincial Cancer Hospital)